1,10-Decanediol, 95.0%, 100g

Methyl 3-bromobenzofuran-5-carboxylate, 95.0%, 250mg

4-(Benzyloxy)-3-methylbenzaldehyde, 98+%, 500mg

4-Methylisoquinolin-3-amine, 95%, 250mg

7-methyl-1H-indazol-6-amine, 98+%, 1g

Objectif à contraste de phase Plan PLPH S100x/1,25

6-Chloro-4-methylpyridazin-3-amine, 95.0%, 5g

2-Cyanoethyltriethoxysilane>98.0%(GC)25mL

TERT-BUTYL ((4-(4-BROMOPHENYL)-1H-IMIDAZOL-2-YL)METHYL)CARBAMATE, 95.0%, 1g

5-AMINOPYRAZINE-2-CARBALDEHYDE HCL, 95.0%, 5g

4-Bromo-1-(3-bromophenyl)-1H-pyrazole, 97%, 100mg

1-(4-Methoxyphenyl)cyclobutanecarbonitrile, 97.0%, 250mg

2-O-tert-Butyl 3-O-ethyl (3S,5R)-5-hydroxy-2-azabicyclo[2.2.2]octane-2,3-dicarboxylate, 95%, 500mg